Skip to content

Comparison of the Effect of Minimal Invasive Lens Surgery and Traditional Cataract Surgery

Comparison of the Effect of Minimal Invasive Lens Surgery and Traditional Cataract Surgery for Treating Congenital Cataracts

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03908359
Enrollment
100
Registered
2019-04-09
Start date
2019-01-01
Completion date
2023-12-31
Last updated
2022-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Cataract

Keywords

Congenital Cataract, minimal invasive surgery, secondary intraocular lens implantation

Brief summary

Previously, the investigators have developed a minimal invasive lens surgery in the purpose of reduce post-operative complications of congenital cataract. This prospective, randomized controlled study aims at comparing the prognosis of the minimal invasive lens surgery and the traditional cataract surgery for treating congenital cataracts.

Detailed description

Patients with congenital cataract that requires surgical intervention are enrolled. Then the participants are assigned to two groups: Group I: the participants receive a minimal invasive lens surgery, while in Group II, the participants receive a traditional cataract surgery. A secondary intraocular lens implantation is performed when the patient is two years old for both Group I and Group II. Investigators then compare the visual acuity, incidence of high intraocular pressure, incidence of visual axis opacification, uveitis and iris/pupil abnormality between two groups, to evaluate and compare the prognosis of minimal invasive lens surgery and traditional cataract surgery for treating congenital cataracts.

Interventions

ACCC+ I/A + PCCC + Anti-vit: anterior continuous capsulorhexis + irrigation/aspiration + posterior capsulorhexis + anterior vitrectomy

We decreased the size of the capsulorhexis opening to 1.0-1.5 mm in diameter. Then we moved the location of the capsulorhexis to the peripheral area of the lens instead of the central area. A 0.9 mm phacoemulsification probe was used to remove the lens contents and/or cortical opacities.

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to 24 Months
Healthy volunteers
No

Inclusion criteria

* Age between 1 month and 24 months * Uncomplicated congenital cataract (≥ 3 mm central dense opacity) in one or both eyes with an intact non-fibrotic capsular bag * Informed consent signed by a parent or legal guardian

Exclusion criteria

* confirmed or suspected hereditary cataract, including and not restricted to family history of congenital cataract * Intraocular pressure \>21 mmHg * Preterm birth (\<28 weeks) * Presence of other ocular diseases (keratitis, keratoleukoma, aniridia, glaucoma) or systemic disease (congenital heart disease, ischemic encephalopathy) * History of ocular diseases (any congenital eye diseases, such as, congenital cataract, congenital glaucoma, congenital aniridia) in the family * History of ocular trauma * Microcornea * Persistent hyperplastic primary vitreous * Rubella * Lowe syndrome

Design outcomes

Primary

MeasureTime frameDescription
Best corrected visual acuityup to five years of ageDetermined with the Teller's acuity card, the Lea symbol visual acuity chart or the ETDRS chart according the patient's age.

Countries

China

Contacts

Primary ContactJing Li, M.D
Reviewborad_SYsU@163.com+86-20-87330341

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026